Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Ponazuril 69004-04-2

Ponazuril 69004-04-2

Inquiry
  Post Date: May 07,2019
  Expiry Date: Nov 03,2019
  Detailed Description: Cas No. :69004-04-2 Ponazuril (INN)is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.

  CAS Registry Number:

69004-04-2
  Synonyms: 1-Methyl-3-(4-(p-((trifluoromethyl)sulfonyl)phenoxy)-m-tolyl)-s-triazine-2,4,6(1H,3H,5H)-trione;Marquis;1-Methyl-3-(4-(p-((trifluoromethyl)sulfonyl)phenoxy)-m-tolyl)-s-triazine-2,4,6(1H,3H,5H)-trione.;1-methyl-3-(3-methyl-4-{4-[(trifluoromethyl)sulfonyl]phenoxy}phenyl)-1,3,5-triazinane-2,4,6-trione;
  Molecular Formula: C18H14F3N3O6S
  Molecular Weight: 457.3805
  Molecular Structure: 69004-04-2 Ponazuril

  Company: Shanghai Neopharm Co., Ltd.     [ China ]          
  Contact: Carol Zhu
  Tel: 021-58826758
  Fax: 021-58827258
  Email: sales@neopharm.com.cn
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.